Contribute Try STAT+ Today

The Indian government has banned exports of hydroxychloroquine, the decades-old malaria drug that was touted by President Trump as a possible weapon in the fight against Covid-19, but has been in short supply.

In a notice posted Wednesday, the Directorate General of Foreign Trade prohibited the medicine and any formulations from being shipped outside of the country, except for companies that must fulfill existing contracts and on humanitarian grounds that would have to be approved on a case-by-case basis by the Ministry of External Affairs.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • With the HC/AZ combo being rushed into “testing” in NY, will anybody, by any chance, be tracking Long QT arrhythmias? Asking for a friend.

  • This decades old drug was handed out to travelers going to countries with potential malaria without regard for any side effects. Now that we are in dire need of the drug, which heretofore has not be made in the U.S., bureauratic NIH doctors are limiting use of this drug with extreme warnings it has not been tested. What about all the highly tested and FDA approved drugs we later find out are causing cancer and other medical conditions….where was the safety in protecting users on these approved drugs? It’s a big pharma/leftist bureauratic hold-up for those in fear of blame over cure. Go Trump…the red-tape destroyer and defender of the people.

  • “Over the past few days, state pharmacy boards in Texas, Ohio, Idaho, and Nevada began restricting who can be prescribed the drugs, after reports of some doctors prescribing the drugs for themselves and their families.”
    When doctors start behaving like this, we may be relaively certain that the drug is useful and with acceptable side effects.

  • Within the post, our scribe again mentions that the Import Alert for some IPCA facilities has been lifted. May I quote the President: “We don’t want the cure to be worse than the disease.” (Or misquote, if you prefer …)
    I will assume US-FDA made “A risk based assessment” or they will say that. (Or perhaps it was based on political risk, at least a bit?)

Comments are closed.